Study on the Effects of Transcutaneous Auricular Acupuncture Stimulation of the Vagus Nerve on Post-Traumatic Cerebral Oedema
Open Access
- 23 March 2026
- journal article
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 25 (3) , 47066
Abstract
Background: Secondary cerebral oedema following traumatic brain injury (TBI) is a major cause of poor prognosis, primarily driven by neuroinflammation. High-mobility group box 1 (HMGB1) is a key damage-associated molecular pattern that initiates a potent inflammatory cascade, yet targeted pharmacological interventions face clinical translation challenges. Non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) has shown anti-inflammatory potential, but its efficacy and specific mechanisms in treating traumatic cerebral oedema remain unclear. Methods: A controlled cortical impact (CCI) model was established in male C57BL/6 mice. The animals were randomly divided into five groups: sham, TBI, TBI + taVNS, TBI + HMGB1 agonist (high glucose), and TBI + HMGB1 antagonist (glycyrrhizic acid). taVNS was administered daily for 7 days. Cerebral oedema volume was quantified via magnetic resonance imaging (MRI) on days 3 and 10 post-injury. Neurological function was assessed using the open field test and modified neurological sign score (mNSS). Molecular mechanisms were investigated through transcriptomic sequencing, enzyme-linked immunosorbent assay (ELISA), western blotting, and immunofluorescence to analyze HMGB1 and downstream inflammatory factors (interleukin-1β (IL-1β), interleukin-6 (IL-6)). Results: Transcriptomic analysis revealed that taVNS reversed TBI-induced dysregulation of genes enriched in HMGB1-related pathways (e.g., Ras-associated protein-1 (Rap1), mitogen-activated protein kinase (MAPK)). Compared with the TBI group, taVNS significantly accelerated the resolution of cerebral oedema (reduction rate: 74.7 ± 12.1% vs 53.5 ± 16.2%, p < 0.05) and improved neurological function. Mechanistically, taVNS markedly suppressed the upregulation of HMGB1, IL-1β, and IL-6 in both serum and brain tissue. Crucially, the therapeutic effects of taVNS were abolished by HMGB1 agonism (high glucose), while HMGB1 antagonism (glycyrrhizic acid) alone mimicked the benefits of taVNS. Conclusions: This study demonstrates that taVNS effectively promotes the resolution of post-traumatic cerebral oedema and facilitates neurological recovery by specifically inhibiting the HMGB1-mediated inflammatory pathway. These findings position taVNS as a promising, non-invasive therapeutic strategy for the early management of secondary brain injury.Keywords
Funding Information
- Anhui University Scientific Research Project (AH2023AH040076)
This publication has 24 references indexed in Scilit:
- HMGB1 blood levels and neurological outcomes after traumatic brain injury: Insights from an exploratory studyEpilepsia Open, 2025
- Neuroinflammation in Acute Ischemic and Hemorrhagic StrokeCurrent Neurology and Neuroscience Reports, 2023
- Traumatic brain injury: progress and challenges in prevention, clinical care, and researchThe Lancet Neurology, 2022
- Comparing imaging biomarkers of cerebral edema after TBI in young adult male and female ratsBrain Research, 2022
- Clinical perspectives on vagus nerve stimulation: present and futureClinical Science, 2022
- Attention and Communication Following TBI: Making the Connection through a Meta-Narrative Systematic ReviewNeuropsychology Review, 2020
- Avoiding off-target effects in electrical stimulation of the cervical vagus nerve: Neuroanatomical tracing techniques to study fascicular anatomy of the vagus nerveJournal of Neuroscience Methods, 2019
- Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhageProgress in Neurobiology, 2019
- Neuroinflammation and blood–brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targetsJournal of Neuroscience Research, 2018
- Novel Therapeutic Strategies for Traumatic Brain Injury: Acute Antioxidant ReinforcementCNS Drugs, 2014